Lydall Completes Acquisition of Gutsche
Jan 03, 2017 13:04 pm UTC| Business
- Solidifies Lydall as a global leader in industrial filtration markets - Further diversifies Lydall into complementary geographies and attractive adjacent markets with a leading brand - Combination creates further...
Lydall Completes Acquisition of Gutsche
Jan 03, 2017 13:04 pm UTC| Business
- Solidifies Lydall as a global leader in industrial filtration markets - Further diversifies Lydall into complementary geographies and attractive adjacent markets with a leading brand - Combination creates further...
Jan 03, 2017 13:04 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., Jan. 03, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firmengaged in the development of effective immunotherapies...
Jan 03, 2017 13:04 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., Jan. 03, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firmengaged in the development of effective immunotherapies...
Jan 03, 2017 13:04 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., Jan. 03, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firmengaged in the development of effective immunotherapies...
Jan 03, 2017 13:04 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., Jan. 03, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firmengaged in the development of effective immunotherapies...
Jan 03, 2017 13:04 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., Jan. 03, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firmengaged in the development of effective immunotherapies...